Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Construction In Progress : ¥1,324 Mil (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Tonghua Dongbao Pharmaceutical Co Construction In Progress?

Tonghua Dongbao Pharmaceutical Co's quarterly construction in progress increased from Sep. 2023 (¥1,267 Mil) to Dec. 2023 (¥1,319 Mil) and increased from Dec. 2023 (¥1,319 Mil) to Mar. 2024 (¥1,324 Mil).

Tonghua Dongbao Pharmaceutical Co's annual construction in progress declined from Dec. 2021 (¥1,203 Mil) to Dec. 2022 (¥1,158 Mil) but then increased from Dec. 2022 (¥1,158 Mil) to Dec. 2023 (¥1,319 Mil).

Tonghua Dongbao Pharmaceutical Co Construction In Progress Historical Data

The historical data trend for Tonghua Dongbao Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Dongbao Pharmaceutical Co Construction In Progress Chart

Tonghua Dongbao Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

1,086.88

1,210.28

1,203.39

1,157.64

1,319.50

Tonghua Dongbao Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															1,200.64	1,218.24	1,266.55	1,319.50	1,324.45

Tonghua Dongbao Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) » Definitions » Construction In Progress

Traded in Other Exchanges

N/A

Address

Dongbao Village, Jilin Province, Tonghua, CHN, 134123

Website

http://www.thdb.com

Tonghua Dongbao Pharmaceutical Co Ltd is a China-based firm. Its engaged in the production and distribution of pharmaceutical products. Its products include human insulin injection, Heart and brain capsule, Vitamin e soft capsule, and Oral detoxification products.

Executives

Cheng Jian Qiu	Supervisors
Chang Xiao Hui	Director
Li Cong	Director
Li Feng Qin	Director
Chen Hong	senior management
Leng Chun Sheng	Director
Li Yi Kui	Director
Wang Dian Duo	Supervisors
Wang Jun Ye	Director
Han Jie	Director

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Headlines

No Headlines